AllianceBernstein Portfolio holdings
AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$567M |
| 2 |
Visa
V
|
+$283M |
| 3 |
CVS Health
CVS
|
+$195M |
| 4 |
Texas Instruments
TXN
|
+$188M |
| 5 |
Progressive
PGR
|
+$187M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$274M |
| 2 |
Microsoft
MSFT
|
+$263M |
| 3 |
Comcast
CMCSA
|
+$248M |
| 4 |
Amphenol
APH
|
+$238M |
| 5 |
Elevance Health
ELV
|
+$238M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.59% |
| 2 | Financials | 14.66% |
| 3 | Healthcare | 14.25% |
| 4 | Consumer Discretionary | 10.15% |
| 5 | Industrials | 10.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
876
DELISTED
Aimmune Therapeutics
AIMT
| $10.4M | 0.01% |
691,242
-50,975
| -7% | -$688K |
|
877
Littelfuse
LFUS
$10.3B
| $10.4M | 0.01% |
80,481
+41,665
| +107% | +$5.11M |
|
878
Ralph Lauren
RL
$22.2B
| $10.4M | 0.01% |
102,414
-5,140
| -5% | -$516K |
|
879
Signet Jewelers
SIG
$3.48B
| $10.3M | 0.01% |
137,849
-2,339
| -2% | -$198K |
|
880
MGIC Investment
MTG
$6.28B
| $10.3M | 0.01% |
1,282,136
+497,340
| +63% | +$3.7M |
|
881
Camden Property Trust
CPT
$11.2B
| $10.3M | 0.01% |
122,475
-193,563
| -61% | -$16.9M |
|
882
BioMarin Pharmaceuticals
BMRN
$11.4B
| $10.2M | 0.01% |
110,602
+1,250
| +1% | +$118K |
|
883
Reliance Steel & Aluminium
RS
$20.6B
| $10.2M | 0.01% |
141,668
+68,275
| +93% | +$5.12M |
|
884
Incyte
INCY
$23.4B
| $10.2M | 0.01% |
108,113
-370
| -0.3% | -$31.2K |
|
|
GRMN
885
Garmin
GRMN
$47B
| $10.2M | 0.01% |
211,770
-10,656
| -5% | -$526K |
|
886
News Corp Class A
NWSA
$14.5B
| $10.1M | 0.01% |
725,758
+5,946
| +0.8% | +$78.5K |
|
|
RBS.PRS.CL
887
DELISTED
The Royal Bank Of Scotland Group
RBS.PRS.CL
| $10.1M | 0.01% |
400,000
| – | – |
|
|
BOLD
888
DELISTED
Audentes Therapeutics, Inc
BOLD
| $10.1M | 0.01% |
+565,838
| New | +$8.59M |
|
889
CALL
iShares MSCI Emerging Markets ETF
EEM
$28.2B
| $9.94M | 0.01% |
265,500
-172,900
| -39% | -$6.32M |
|
|
BCS.PRA.CL
890
DELISTED
Barclays Bank Plc Series 3
BCS.PRA.CL
| $9.84M | 0.01% |
382,308
-10,844
| -3% | -$280K |
|
|
CVG
891
DELISTED
Convergys
CVG
| $9.82M | 0.01% |
322,940
+123,980
| +62% | +$3.51M |
|
892
iShares MSCI Global Gold Miners ETF
RING
$2.32B
| $9.82M | 0.01% |
+441,498
| New | +$10.7M |
|
893
SBA Communications
SBAC
$18.9B
| $9.76M | 0.01% |
87,035
-576
| -0.7% | -$65.1K |
|
894
EPR Properties
EPR
$4.82B
| $9.71M | 0.01% |
123,336
+14,861
| +14% | +$1.19M |
|
895
Markel Group
MKL
$24.9B
| $9.67M | 0.01% |
10,416
-96
| -0.9% | -$89.6K |
|
896
PUT
iShares Mortgage Real Estate ETF
REM
$545M
| $9.56M | 0.01% |
+227,500
| New | +$9.65M |
|
897
Annaly Capital Management
NLY
$16.9B
| $9.44M | 0.01% |
224,677
+34,065
| +18% | +$1.48M |
|
898
Robert Half
RHI
$3.6B
| $9.22M | 0.01% |
243,469
-967,187
| -80% | -$36.9M |
|
899
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.67B
| $9.21M | 0.01% |
7,035
+74
| +1% | +$99.2K |
|
900
Deluxe
DLX
$1.2B
| $9.13M | 0.01% |
136,578
+24,320
| +22% | +$1.65M |
|
Similar funds
AllianceBernstein's Q3 2016 Portfolio in Review
As of Q3 2016, AllianceBernstein held 3,058 positions worth $118B, up 2% from $116B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AllianceBernstein's Q3 2016 filing shows 95 new, 1,049 increased, 1,331 reduced and 82 closed positions. Its largest new stake was Teva Pharmaceuticals: 2,294,681 shares worth $106M. The largest sale was Pfizer, an estimated $274M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.
- AllianceBernstein's largest Q3 2016 buy was Teva Pharmaceuticals: 2,294,681 shares worth $106M.
- AllianceBernstein added most to State Street SPDR S&P 500 ETF Trust in Q3 2016, an estimated $567M increase.
- AllianceBernstein's biggest Q3 2016 reduction was Pfizer, cutting an estimated $274M.
- AllianceBernstein fully exited EMC CORPORATION in Q3 2016, selling an estimated $99.6M.
- AllianceBernstein's ten largest holdings make up 14% of its $118B portfolio in Q3 2016.
- AllianceBernstein opened 95 new positions and closed 82 in Q3 2016.
- AllianceBernstein's portfolio value rose 2% quarter-over-quarter to $118B.
Based on AllianceBernstein's 13F filing for Q3 2016, filed 10 Nov 2016.